Caledonia Investments (LON:CLDN) Insider Robert Memmott Buys 40 Shares of Stock

Caledonia Investments Plc (LON:CLDN) insider Robert Memmott purchased 40 shares of the firm’s stock in a transaction that occurred on Tuesday, January 27th. The stock was bought at an average cost of GBX 374 per share, for a total transaction of £149.60.

Robert Memmott also recently made the following trade(s):

• On Monday, December 15th, Robert Memmott acquired 39 shares of Caledonia Investments stock. The shares were purchased at an average price of GBX 386 per share, with a total value of £150.54.
• On Thursday, November 27th, Robert Memmott bought 39 shares of Caledonia Investments stock. The stock was purchased at an average price of GBX 382 per share, for a total transaction of £148.98.

Caledonia Investments Stock Performance

Shares of CLDN opened at GBX 374.13 on Thursday. Caledonia Investments Plc has a one year low of GBX 321.50 and a one year high of GBX 395. The stock has a market capitalization of £1.95 billion, a price-to-earnings ratio of 10.83 and a beta of 0.77. The stock has a 50 day moving average price of GBX 380 and a 200 day moving average price of GBX 580.53.

Caledonia Investments (LON:CLDN) last announced its earnings results on Tuesday, November 25th. The company reported GBX 7.30 earnings per share (EPS) for the quarter. Caledonia Investments had a net margin of 86.28% and a return on equity of 6.98%.

Caledonia Investments Company Profile

Caledonia is a FTSE 250 self-managed investment trust company with a long track record of delivering consistent returns and progressive annual dividend payments to shareholders.

Our aim is to generate long-term compounding real returns that outperform inflation by 3%-6% over the medium to long term, and the FTSE All-Share index over 10 years.

We are a long-term investor and hold investments in both listed and private markets across three pools: Public Companies, Private Capital and Funds. Each has a strategic allocation of capital, investment strategy and target return.

We buy to hold, investing in high quality companies with strong market positions and fundamentals, alongside investments in private equity funds with track records of success.